• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 6-K filed by Aluminum Corporation of China Limited

    1/26/24 8:19:20 AM ET
    $ACH
    Medical Specialities
    Health Care
    Get the next $ACH alert in real time by email
    6-K 1 d6k_A099.htm 6-kAnnouncement


    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    ___________________

    FORM 6-K
    ___________________

    Report of Foreign Private Issuer

    Pursuant to Rule 13a-16 or 15d-16 of
    the Securities Exchange Act of 1934

    For the Month of January 2024

    Commission File Number: 001-15264
    ___________________

    Aluminum Corporation of China Limited
    (Translation of registrant's name into English)
    ___________________

    No. 62 North Xizhimen Street
    Haidian District, Beijing
    People's Republic of China 100082

    (Address of principal executive offices)
    ___________________

             Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

    Form 20-F      X       Form 40-F               

             Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): __________

             Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): __________


    EXHIBITS

    Exhibit
    Number

     

    99.1

    OVERSEAS REGULATORY ANNOUNCEMENT AND INSIDE INFORMATION - ANNOUNCEMENT ON ESTIMATED PROFIT INCREASE FOR THE YEAR OF 2023

     

     

    FORWARD-LOOKING STATEMENTS

    Certain statements contained in this announcement may be regarded as "forward-looking statements" within the meaning of the U.S. Securities Exchange Act of 1934, as amended. Such forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause the actual performance, financial condition or results of operations of the Company to be materially different from any future performance, financial condition or results of operations implied by such forward-looking statements. Further information regarding these risks, uncertainties and other factors is included in the Company's filings with the U.S. Securities and Exchange Commission. The forward-looking statements included in this announcement represent the Company's views as of the date of this announcement. While the Company anticipates that subsequent events and developments may cause the Company's views to change, the Company specifically disclaims any obligation to update these forward-looking statements, unless required by applicable laws. These forward-looking statements should not be relied upon as representing the Company's views as of any date subsequent to the date of this announcement.


    SIGNATURES

              Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

     

      Aluminum Corporation of China Limited         
                                                       (Registrant)

     

    Date  January 26, 2024       

     

    By                 /s/    Ge Xiaolei                     
    Name: Ge Xiaolei
    Title: Company Secretary

     

     

     

     

     

    Exhibit 99.1

    About the Company

    Our contact information of this release is:

    *

    Business address: No. 62 North Xizhimen Street, Haidian District, Beijing, People's Republic of China, 100082

    *

    Telephone number: (86-10) 8229 8322

    *

    Website: http://www.chalco.com.cn

    *

    Contact person: Ge Xiaolei, Company Secretary

    Get the next $ACH alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACH

    DatePrice TargetRatingAnalyst
    8/25/2022Sell → Neutral
    Goldman
    3/23/2022Reduce → Hold
    HSBC Securities
    More analyst ratings

    $ACH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Accendra Health Reports Fourth Quarter 2025 Financial Results

    Completed Sale of Products & Healthcare Services Business On December 31, 2025 Strong Cash Flow and Debt Reduction In Quarter Accendra Health, Inc. (NYSE:ACH) today reported financial results for the fourth quarter ended December 31, 2025. Unless otherwise noted, the results herein reflect the Company's continuing operations, which primarily represent what was previously the Patient Direct segment and certain functional operations. "We ended the fourth quarter with the completion of the sale of the Products & Healthcare Services (P&HS) business on December 31, 2025, and we are extremely excited to embark on the next chapter of our business as Accendra Health. The next several months w

    2/19/26 4:05:00 PM ET
    $ACH
    Medical Specialities
    Health Care

    Accendra Health Announces Fourth Quarter 2025 Earnings Release Date and Conference Call

    Accendra Health, Inc. (NYSE:ACH) (the "Company") plans to release financial results for the fourth quarter of 2025 on Thursday, February 19, 2026, after trading ends on the New York Stock Exchange. The Company will host a conference call for investors and analysts at 5:00 p.m. EST on the same day. Participants may access the call via the toll-free dial-in number at 1-888-300-2035, or the toll dial-in number at 1-646-517-7437. The conference ID access code is 1058917. All interested stakeholders are encouraged to access the simultaneous live webcast by visiting the Investor Relations page of the Accendra Health website available at investors.accendra.com/events-and-presentations/. A repl

    2/5/26 4:05:00 PM ET
    $ACH
    Medical Specialities
    Health Care

    Accendra Health, Inc. to Begin Trading on NYSE under New Ticker "ACH"

    Accendra Health, Inc. (NYSE:ACH) (the "Company") announced that the Company's common stock will begin trading on the New York Stock Exchange under its new ticker symbol, "ACH", effective today. The Company also announced the launch of its new website, www.accendrahealth.com. On December 31, 2025, the Company announced the completion of the sale of its former Products & Healthcare Services business along with the Owens & Minor brand. Safe Harbor This release is intended to be disclosure through methods reasonably designed to provide broad, non-exclusionary distribution to the public in compliance with the SEC's Fair Disclosure Regulation. This release contains certain "forward looking" s

    1/2/26 6:30:00 AM ET
    $ACH
    Medical Specialities
    Health Care

    $ACH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Alum. Corp China upgraded by Goldman

    Goldman upgraded Alum. Corp China from Sell to Neutral

    8/25/22 1:04:06 PM ET
    $ACH
    Medical Specialities
    Health Care

    Alum. Corp China upgraded by HSBC Securities

    HSBC Securities upgraded Alum. Corp China from Reduce to Hold

    3/23/22 7:04:02 AM ET
    $ACH
    Medical Specialities
    Health Care

    Alum. Corp China upgraded by JP Morgan

    JP Morgan upgraded Alum. Corp China from Neutral to Overweight

    4/8/21 12:27:37 PM ET
    $ACH
    Medical Specialities
    Health Care

    $ACH
    SEC Filings

    View All

    SEC Form 10-K filed by Accendra Health Inc.

    10-K - ACCENDRA HEALTH INC/VA/ (0000075252) (Filer)

    2/20/26 4:19:33 PM ET
    $ACH
    Medical Specialities
    Health Care

    Accendra Health Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - ACCENDRA HEALTH INC/VA/ (0000075252) (Filer)

    2/19/26 4:10:24 PM ET
    $ACH
    Medical Specialities
    Health Care

    SEC Form 15F-12B filed by Aluminum Corporation of China Limited

    15F-12B - ALUMINUM CORP OF CHINA LTD (0001161611) (Filer)

    2/2/24 6:02:12 AM ET
    $ACH
    Medical Specialities
    Health Care

    $ACH
    Financials

    Live finance-specific insights

    View All

    Accendra Health Reports Fourth Quarter 2025 Financial Results

    Completed Sale of Products & Healthcare Services Business On December 31, 2025 Strong Cash Flow and Debt Reduction In Quarter Accendra Health, Inc. (NYSE:ACH) today reported financial results for the fourth quarter ended December 31, 2025. Unless otherwise noted, the results herein reflect the Company's continuing operations, which primarily represent what was previously the Patient Direct segment and certain functional operations. "We ended the fourth quarter with the completion of the sale of the Products & Healthcare Services (P&HS) business on December 31, 2025, and we are extremely excited to embark on the next chapter of our business as Accendra Health. The next several months w

    2/19/26 4:05:00 PM ET
    $ACH
    Medical Specialities
    Health Care

    Accendra Health Announces Fourth Quarter 2025 Earnings Release Date and Conference Call

    Accendra Health, Inc. (NYSE:ACH) (the "Company") plans to release financial results for the fourth quarter of 2025 on Thursday, February 19, 2026, after trading ends on the New York Stock Exchange. The Company will host a conference call for investors and analysts at 5:00 p.m. EST on the same day. Participants may access the call via the toll-free dial-in number at 1-888-300-2035, or the toll dial-in number at 1-646-517-7437. The conference ID access code is 1058917. All interested stakeholders are encouraged to access the simultaneous live webcast by visiting the Investor Relations page of the Accendra Health website available at investors.accendra.com/events-and-presentations/. A repl

    2/5/26 4:05:00 PM ET
    $ACH
    Medical Specialities
    Health Care

    $ACH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed

    SC 13G/A - ALUMINUM CORP OF CHINA LTD (0001161611) (Subject)

    2/16/21 3:46:32 PM ET
    $ACH
    Medical Specialities
    Health Care